This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Royal College of Surgeons in Ireland. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by Jansen Seheult in Medication Adherence Monitoring
Introduction
Jansen Seheult is an innovative inventor based in Dublin, Ireland. He has made significant contributions to the field of healthcare through his patented invention aimed at improving medication adherence among patients. His work is crucial in addressing the challenges faced by patients in managing their medication schedules effectively.
Latest Patents
Jansen Seheult holds a patent for a "Method for monitoring adherence to medication." This invention provides a systematic approach to tracking whether patients are following their prescribed medication regimens. The method involves obtaining timing data for each dose taken by the patient over a specified time interval. It estimates the concentration of the medication in the patient's body based on this timing data. Furthermore, it determines the proportion of time the medication concentration exceeds a target level and calculates an adherence score for the patient based on this data.
Career Highlights
Jansen Seheult is associated with the Royal College of Surgeons in Ireland, where he contributes to research and development in the medical field. His work focuses on enhancing patient care through innovative solutions that leverage technology to monitor health outcomes effectively.
Collaborations
Some of Jansen's notable coworkers include Garrett Greene and Richard Costello. Their collaborative efforts contribute to the advancement of medical technologies and improve patient adherence to treatment protocols.
Conclusion
Jansen Seheult's innovative approach to monitoring medication adherence represents a significant advancement in healthcare technology. His patent not only addresses a critical issue in patient management but also showcases the potential for future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
